Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Medical management of bronchiectasis.

Literature DB >> 30505530

Medical management of bronchiectasis.

Abstract

The medical management of bronchiectasis includes confirming the diagnosis of the disease, evaluating the patient for possible underlying etiologies and then properly assessing the patient for appropriate therapies. Patients with bronchiectasis are heterogeneous and a personalized approach to each patient is needed in order to properly formulate an optimal management plan.

Entities: Species

Keywords: Bronchiectasis; airway clearance; lung infection

Year: 2018 PMID： 30505530 PMCID： PMC6218363 DOI： 10.21037/jtd.2018.09.39

Source DB: PubMed Journal: J Thorac Dis ISSN： 2072-1439 Impact factor: 2.895

45 in total

1. Surgical treatment of atypical mycobacterial infections.

Authors: Jessica A Yu; Michael J Weyant; John D Mitchell
Journal: Thorac Surg Clin Date: 2012-08 Impact factor: 1.750

2. Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007.

Authors: Amy E Seitz; Kenneth N Olivier; Jennifer Adjemian; Steven M Holland; D Rebecca Prevots
Journal: Chest Date: 2012-08 Impact factor: 9.410

3. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group.

Authors: A E O'Donnell; A F Barker; J S Ilowite; R B Fick
Journal: Chest Date: 1998-05 Impact factor: 9.410

4. Aerosolized Antibiotics for Patients with Bronchiectasis.

Authors: Tejaswi R Nadig; Patrick A Flume
Journal: Am J Respir Crit Care Med Date: 2016-04-01 Impact factor: 21.405

5. Upright positive expiratory pressure therapy and exercise: effects on gastroesophageal reflux in COPD and bronchiectasis.

Authors: Annemarie L Lee; Linda Denehy; John W Wilson; Stuart Roberts; Robert G Stirling; Ralf G Heine; Brenda M Button
Journal: Respir Care Date: 2012-02-17 Impact factor: 2.258

6. A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis.

Authors: Paul Scheinberg; Eric Shore
Journal: Chest Date: 2005-04 Impact factor: 9.410

7. Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study.

Authors: Melissa J McDonnell; Stefano Aliberti; Pieter C Goeminne; Marcos I Restrepo; Simon Finch; Alberto Pesci; Lieven J Dupont; Thomas C Fardon; Robert Wilson; Michael R Loebinger; Dusan Skrbic; Dusanka Obradovic; Anthony De Soyza; Chris Ward; John G Laffey; Robert M Rutherford; James D Chalmers
Journal: Lancet Respir Med Date: 2016-11-16 Impact factor: 30.700

8. Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection.

Authors: Charles S Haworth; Juliet E Foweraker; Peter Wilkinson; Robert F Kenyon; Diana Bilton
Journal: Am J Respir Crit Care Med Date: 2014-04-15 Impact factor: 21.405

Review 9. Inhaled therapy in cystic fibrosis: agents, devices and regimens.

Authors: Penny Agent; Helen Parrott
Journal: Breathe (Sheff) Date: 2015-06

10. Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial.

Authors: David J Serisier; Diana Bilton; Anthony De Soyza; Philip J Thompson; John Kolbe; Hugh W Greville; David Cipolla; Paul Bruinenberg; Igor Gonda
Journal: Thorax Date: 2013-05-16 Impact factor: 9.139

5 in total

5. Prognostic performance of the FACED score and bronchiectasis severity index in bronchiectasis: a systematic review and meta-analysis.

Authors: Min He; Min Zhu; Chengdi Wang; Zuohong Wu; Xiaofeng Xiong; Hongxia Wu; Deyun Cheng; Yulin Ji
Journal: Biosci Rep Date: 2020-10-30 Impact factor: 3.840